Get insight from foundation experts on research, treatment and prevention, plus the very latest news and events.
Switch on your HIV smarts.
I wasn’t sure I wanted to go to therapy. Did I have the money? Did I have the time? I wasn’t miserable, after all, but was I happy? Well, not … Read More
This week, the FDA granted approval of Gilead Science’s single-tablet combo pill of bictegravir, emtricitabine (FTC) and tenofovir alafenamide (TAF) named Biktarvy. Read on for additional information about what we … Read More
Join us for daily news and commentary on HIV/AIDS treatment, prevention and policy.